Mi-Helper
Baltimore, US · Founded 2021 · Delaware corporation
MiHelper develops a medical device and runs clinical trials in the area of headache and migraine treatment, working with headache neurologists and clinical research specialists. It operates in the medtech and digital health space with a focus on neurology.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$4M disclosed across 1 round · 2022
▶$4MraisedOct 2022 · 3 investors · BiotechnologyRule 506(b)
▶$4MraisedOct 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven E. SchaeferExecutive Officer, Director
- Harikrishna TandriDirector
- Keith SullivanDirector
- Brian LipfordDirector
- Eileen O'RourkeDirector
- Offering amount
- $7M
- Amount sold
- $4M
- Proceeds to insiders
- $500K
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Mi-Helper do?
- MiHelper develops a medical device and runs clinical trials in the area of headache and migraine treatment, working with headache neurologists and clinical research specialists. It operates in the medtech and digital health space with a focus on neurology.
- How much funding has Mi-Helper raised?
- Mi-Helper has disclosed $4M raised across 1 round.
- Where is Mi-Helper headquartered?
- Mi-Helper is headquartered in Baltimore, US.